Maxim Downgrades ZIVO Bioscience Stock Rating to 'Hold', Eliminates Price Target
Tuesday, 4 June 2024, 11:19
Maxim Downgrades ZIVO Bioscience Stock Rating
In a recent report, Maxim downgraded ZIVO Bioscience stock rating to 'Hold' and eliminated the price target.
Implications of the Downgrade
- This decision signifies a change in the company's perceived performance.
- Investors are urged to stay informed about the developments in relation to this downgrade.
This significant shift in the stock rating and target removal by Maxim necessitates vigilance among investors and a reassessment of the company's future prospects.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.